Brii Bio acquires Vir’s antibody rights for Hepatitis B in Greater China
The development adds further growth to Brii Bio’s clinical pipeline of therapeutic candidates for HBV.
Infectious Disease
Latest in
Infectious Disease
Oxford Biomedica, AstraZeneca enter new deal for Covid-19 vaccine
According to the new deal, AstraZeneca will have access to Covid-19 vaccine manufacturing at Oxford Biomedica’s Oxbox facility.
Pfizer seeks approval from US FDA for Covid-19 treatment
The filing is based on non-clinical and clinical data for Paxlovid and also comprised data from the Phase II/III EPIC-HR…
Neglected tropical diseases: non-profits lead the way as private sectors lags
The Covid-19 pandemic has put extra pressure on research for neglected tropical diseases, but developments continue
By
HDT Bio receives Emergency Use Approval for Covid-19 vaccine in India
Gemcovac became the first saRNA vaccine to obtain approval for use in humans in India.
Pfizer and BioNTech enter $3.2bn deal with US Government for Covid-19 shots
This deal might comprise Omicron-adapted Covid-19 vaccines contingent on obtaining the US FDA authorisation.
Japan’s MHLW accepts GSK’s submission for shingles vaccine in adults
The filing is based on data from six clinical trials in subjects of the age 18 years and above.
Rensselaer team receives NIAID grant to develop antiviral drug for Covid-19
Seven of the ten hepatitis C therapies analysed were found to suppress the SARS-CoV-2 virus.